Literature DB >> 9311350

Spinocerebellar ataxia type 2. Genotype and phenotype in German kindreds.

L Schöls1, S Gispert, M Vorgerd, A M Menezes Vieira-Saecker, P Blanke, G Auburger, G Amoiridis, S Meves, J T Epplen, H Przuntek, S M Pulst, O Riess.   

Abstract

BACKGROUND: Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant cerebellar ataxia (ADCA) for which the disease-causing mutation has recently been characterized as an expanded CAG trinucleotide repeat. We investigated 64 families of German ancestry with ADCA and 55 patients with sporadic ataxia for the SCA2 mutation.
RESULTS: Expanded alleles were found in 6 of the 64 families and in 1 patient with sporadic ataxia. This patient had a de novo mutation from an intermediate paternal allele. Length of repeats in 21 patients with SCA2 ranged from 36 to 52 CAG motifs and was inversely correlated with age at onset and progression of the disease. Expanded alleles were unstable during meiosis; paternal transmission especially caused significant anticipation of onset up to 26 years earlier. The SCA2 phenotype differed from those of SCA1 and SCA3 with higher frequencies of slowed ocular movements, postural and action tremor, myoclonus, and hyporeflexia. However, no single feature was sufficient to permit a specific clinical diagnosis.
CONCLUSIONS: Spinocerebellar ataxia type 2 accounts for about 10% of German families with ADCA but may also be present in sporadic ataxia due to de novo mutations. Clinical features are highly variable among and even within families. However, the size of the expanded repeat influences the phenotype and is relevant for course and prognosis of the disease.

Entities:  

Mesh:

Year:  1997        PMID: 9311350     DOI: 10.1001/archneur.1997.00550210011007

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  23 in total

Review 1.  The complex clinical and genetic classification of inherited ataxias. I. Dominant ataxias.

Authors:  S Di Donato
Journal:  Ital J Neurol Sci       Date:  1998-12

2.  The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study.

Authors:  H Jacobi; P Bauer; P Giunti; R Labrum; M G Sweeney; P Charles; A Dürr; C Marelli; C Globas; C Linnemann; L Schöls; M Rakowicz; R Rola; E Zdzienicka; T Schmitz-Hübsch; R Fancellu; C Mariotti; C Tomasello; L Baliko; B Melegh; A Filla; C Rinaldi; B P van de Warrenburg; C C P Verstappen; S Szymanski; J Berciano; J Infante; D Timmann; S Boesch; S Hering; C Depondt; M Pandolfo; J-S Kang; S Ratzka; J Schulz; S Tezenas du Montcel; T Klockgether
Journal:  Neurology       Date:  2011-08-10       Impact factor: 9.910

Review 3.  Clinical, psychological, and genetic characteristics of spinocerebellar ataxia type 19 (SCA19).

Authors:  H Jurgen Schelhaas; Bart P C van de Warrenburg
Journal:  Cerebellum       Date:  2005       Impact factor: 3.847

4.  Therapeutic prospects for spinocerebellar ataxia type 2 and 3.

Authors:  Ilya Bezprozvanny; Thomas Klockgether
Journal:  Drugs Future       Date:  2009-12       Impact factor: 0.148

Review 5.  Essential Tremor Within the Broader Context of Other Forms of Cerebellar Degeneration.

Authors:  Elan D Louis; Phyllis L Faust
Journal:  Cerebellum       Date:  2020-12       Impact factor: 3.847

6.  Spinocerebellar ataxia types 1, 2, 3 and 6: the clinical spectrum of ataxia and morphometric brainstem and cerebellar findings.

Authors:  Heike Jacobi; Till-Karsten Hauser; Paola Giunti; Christoph Globas; Peter Bauer; Tanja Schmitz-Hübsch; László Baliko; Alessandro Filla; Caterina Mariotti; Maria Rakowicz; Perine Charles; Pascale Ribai; Sandra Szymanski; Jon Infante; Bart P C van de Warrenburg; Alexandra Dürr; Dagmar Timmann; Sylvia Boesch; Roberto Fancellu; Rafal Rola; Chantal Depondt; Ludger Schöls; Elzbieta Zdzienicka; Jun-Suk Kang; Susanne Ratzka; Berry Kremer; Dennis A Stephenson; Béla Melegh; Massimo Pandolfo; Sophie Tezenas du Montcel; Johannes Borkert; Jörg B Schulz; Thomas Klockgether
Journal:  Cerebellum       Date:  2012-03       Impact factor: 3.847

7.  Molecular and clinical study of 18 families with ADCA type II: evidence for genetic heterogeneity and de novo mutation.

Authors:  P Giunti; G Stevanin; P F Worth; G David; A Brice; N W Wood
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

Review 8.  12q24 locus association with type 1 diabetes: SH2B3 or ATXN2?

Authors:  Georg Auburger; Suzana Gispert; Suna Lahut; Ozgür Omür; Ewa Damrath; Melanie Heck; Nazlı Başak
Journal:  World J Diabetes       Date:  2014-06-15

9.  Spinocerebellar ataxia type 2 (SCA2) in an Egyptian family presenting with polyphagia and marked CAG expansion in infancy.

Authors:  Alice Abdel-Aleem; Maha S Zaki
Journal:  J Neurol       Date:  2008-02-26       Impact factor: 4.849

Review 10.  Spinocerebellar ataxia 2 (SCA2).

Authors:  Isabel Lastres-Becker; Udo Rüb; Georg Auburger
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.